Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1997 | 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,554 | 58,497 | 59,420 | 52,698 | 104,068 |
| Marketable Securities | 7,327 | 22,051 | 23,699 | 25,432 | 40,357 |
| Receivables | 302,009 | 298,886 | 283,017 | 266,284 | 229,034 |
| Inventories | 253,654 | 226,213 | 209,837 | 190,331 | 169,391 |
| Other current assets | 129,891 | 143,231 | 66,551 | 48,581 | 31,227 |
| TOTAL | $764,435 | $748,878 | $642,524 | $583,326 | $574,077 |
| Non-Current Assets | |||||
| PPE Net | N/A | 505,374 | N/A | N/A | N/A |
| Investments And Advances | 105,248 | 77,890 | 83,354 | 0 | 0 |
| Other Non-Current Assets | 308,230 | 338,174 | 311,923 | 387,214 | 397,968 |
| TOTAL | $413,478 | $921,438 | $395,277 | $387,214 | $397,968 |
| Total Assets | $1,559,586 | $1,512,128 | $1,357,151 | $1,257,735 | $1,241,599 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 0 | 156,334 |
| Accounts payable and accrued liabilities | 147,020 | 64,453 | 147,107 | 116,947 | 109,718 |
| Accrued Expenses | 32,223 | 131,951 | 65,116 | 71,064 | 101,695 |
| Other current liabilities | 3,201 | 1,929 | 54,493 | 16,601 | 45,072 |
| TOTAL | $456,996 | $463,823 | $492,699 | $465,336 | $412,819 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 72,048 | 72,059 | 33,323 | 41,833 | 33,278 |
| TOTAL | $132,023 | $132,034 | $33,323 | $41,833 | $33,278 |
| Total Liabilities | $589,019 | $595,857 | $526,022 | $507,169 | $446,097 |
| Shareholders' Equity | |||||
| Common Shares | 1,791 | 1,791 | 1,791 | 1,791 | 1,791 |
| Retained earnings | 657,666 | 585,057 | 508,313 | 440,470 | 416,960 |
| Other shareholders' equity | -56,673 | -27,544 | -19,803 | -11,490 | -6,047 |
| TOTAL | $970,567 | $916,271 | $831,129 | $750,566 | $795,502 |
| Total Liabilities And Equity | $1,559,586 | $1,512,128 | $1,357,151 | $1,257,735 | $1,241,599 |